OrphanDrug
OrphanDrug
Pharma Knowledge Base

ataxia-oculomotor apraxia type 4

ORPHA: 459033

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with ataxia-oculomotor apraxia type 4, sourced from HPO and Orphanet clinical annotations.

Somatic sensory dysfunctionMuscular dystrophyPes cavusDistal lower limb muscle weaknessCognitive impairmentDyscalculiaDyslexiaShort attention spanObesitySensorimotor neuropathyKyphoscoliosisAbnormal saccadic eye movementsDysarthriaAtaxiaOculomotor apraxiaPeripheral neuropathyDystoniaPostural instabilityAbnormal toe morphologyProgressive distal muscular atrophy

Classification & Codes

Orphanet Code

ORPHA:459033
ataxia-oculomotor apraxia type 4
OrphanetORPHA:459033
Treatments0 drug(s)
Symptoms on record20 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO